Novartis Sues Dr. Reddy's, Watson Over ANDAs For Generic Exelon
Swiss pharmaceutical giant Novartis has filed two separate patent infringement lawsuits against generic makers Dr. Reddy's and Watson Pharmaceuticals in response to their plans to make generic versions of Alzheimer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article